Identification of adulterants in a Chinese herbal medicine by LC-HRMS and LC-MS-SPE/NMR and comparative in vivo study with standards in a hypertensive rat model.
about
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesIdentification of common horsetail (Equisetum arvense L.; Equisetaceae) using Thin Layer Chromatography versus DNA barcodingIdentification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).Analytical methods for the detection of undeclared synthetic drugs in traditional herbal medicines as adulterants.Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques--state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS hyphenations.Capillary electrophoretic methods for the screening and determination of pharmacologic adulterants in herbal-based pharmaceutical formulations.Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: a review.Synthesis of pro-apoptotic indapamide derivatives as anticancer agents.Biomolecules and Natural Medicine Preparations: Analysis of New Sources of Bioactive Compounds from Ribes and Rubus spp. Buds.Botanicals in Ribes nigrum bud-preparations: an analytical fingerprinting to evaluate the bioactive contribution to total phytocomplex.Validated chromatographic methods for determination of perindopril and amlodipine in pharmaceutical formulation in the presence of their degradation products.Castanea spp. buds as a phytochemical source for herbal preparations: botanical fingerprint for nutraceutical identification and functional food standardisation.Feasibility of UV-VIS-Fluorescence spectroscopy combined with pattern recognition techniques to authenticate a new category of plant food supplements.
P2860
Q26767376-9B467CC1-760C-455F-8731-6D33C4F8E569Q35688974-B983E6BD-11B6-4E43-B610-4861CB307DECQ36889176-B1E87BE4-2B67-4914-B6B7-1638B621708CQ38105047-213DC7B4-6C2F-4BC1-8365-B1934D729D37Q38112324-D4B844A5-DE00-4F85-95A5-9DD58D240496Q38234798-9620BB88-CEC7-4AD6-B9BF-B88A4DF43F76Q38255743-84064A19-0C38-45B3-AEC1-02988054516AQ38909487-558ED8E3-7BB7-4A9D-B572-372058085079Q39649664-E9DBE06E-6E1C-4EF9-8298-21D12C34C9D0Q44973622-449BF36A-20D8-4028-8462-0122876F067CQ46250788-A08A1BD5-B968-462A-836E-CB54FE974463Q46913217-5FE88C29-74D8-4F3C-A88C-745C63846220Q48354427-6F241253-8D66-49A2-934A-D3FB3D45B299
P2860
Identification of adulterants in a Chinese herbal medicine by LC-HRMS and LC-MS-SPE/NMR and comparative in vivo study with standards in a hypertensive rat model.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Identification of adulterants ...... s in a hypertensive rat model.
@en
Identification of adulterants ...... s in a hypertensive rat model.
@nl
type
label
Identification of adulterants ...... s in a hypertensive rat model.
@en
Identification of adulterants ...... s in a hypertensive rat model.
@nl
prefLabel
Identification of adulterants ...... s in a hypertensive rat model.
@en
Identification of adulterants ...... s in a hypertensive rat model.
@nl
P2093
P1476
Identification of adulterants ...... s in a hypertensive rat model.
@en
P2093
Dan Sørensen
Jingqi Huang
Julie Regitze Kesting
P304
P356
10.1016/J.JPBA.2009.09.043
P577
2009-10-02T00:00:00Z